EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis

Maytham Hussein iD, Zetao Sun, Jane Hawkey, Rafah Allobawi, Louise M Judd iD, Vincenzo Carbone, Rajnikant Sharma, Varsha Thombare, Mark Baker, Gauri G Rao iD, Jian Li iD, Kathryn E Holt iD und 1 weitere

mSystems · 2024

DOI: 10.1128/msystems.00972-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2024. Verfasst von Maytham Hussein und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Monash Biomedicine Discovery Institute,Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Klebsiella Infections, Urinary Tract Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitrofurantoin is a commonly used chemotherapeutic agent in the treatment of uncomplicated urinary tract infections caused by the problematic multidrug resistant Gram-negative pathogen Klebsiella pneumoniae . The present study aims to elucidate the mechanism of nitrofurantoin action and high-level resistance in K. pneumoniae using whole-genome sequencing (WGS), qPCR analysis, mutation structural modeling and untargeted metabolomic analysis. WGS profiling of evolved highly resistant mutants (nitrofurantoin minimum inhibitory concentrations > 256 mg/L) revealed modified expression of several genes related to membrane transport (porin ompK36 and efflux pump regulator oqxR ) and nitroreductase activity ( ribC and nfsB , involved in nitrofurantoin reduction). Untargeted metabolomics analysis of total metabolites extracted at 1 and 4 h post-nitrofurantoin treatment revealed that exposure to the drug caused a delayed effect on the metabolome which was most pronounced after 4 h. Pathway enrichment analysis illustrated that several complex interrelated metabolic pathways related to nitrofurantoin bacterial killing (aminoacyl-tRNA biosynthesis, purine metabolism, central carbohydrate metabolism, and pantothenate and CoA biosynthesis) and the development of nitrofurantoin resistance (riboflavin metabolism) were significantly perturbed. This study highlights for the first time the key role of efflux pump regulator oqxR in nitrofurantoin resistance and reveals global metabolome perturbations in response to nitrofurantoin, in K. pneumoniae . IMPORTANCE A quest for novel antibiotics and revitalizing older ones (such as nitrofurantoin) for treatment of difficult-to-treat Gram-negative bacterial infections has become increasingly popular. The precise antibacterial activity of nitrofurantoin is still not fully understood. Furthermore, although the prevalence of nitrofurantoin resistance remains low currently, the drug’s fast-growing consumption worldwide highlights the need to comprehend the emerging resistance mechanisms. Here, we used multidisciplinary techniques to discern the exact mechanism of nitrofurantoin action and high-level resistance in Klebsiella pneumoniae , a common cause of urinary tract infections for which nitrofurantoin is the recommended treatment. We found that the expression of multiple genes related to membrane transport (including active efflux and passive diffusion of drug molecules) and nitroreductase activity was modified in nitrofurantoin-resistant strains, including oqxR, the transcriptional regulator of the oqxAB efflux pump. Furthermore, complex interconnected metabolic pathways that potentially govern the nitrofurantoin-killing mechanisms (e.g., aminoacyl-tRNA biosynthesis) and nitrofurantoin resistance (riboflavin metabolism) were significantly inhibited following nitrofurantoin treatment. Our study could help inform the improvement of nitrofuran derivatives, the development of new pharmacophores, or drug combinations to support the resurgence of nitrofurantoin in the management of multidrug resistant K. pneumouniae infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella InfectionsUrinary Tract InfectionsHumansNitrofurantoinKlebsiella pneumoniaeDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsGenomicsNitroreductasesRiboflavinRNA, Transfer

Stichwörter der Autor:innen

Klebsiella pneumoniaeantimicrobial resistancegenomicsmetabolomicsnitrofurantoin

Substanzen

NitrofurantoinAnti-Bacterial AgentsNitroreductasesRiboflavinRNA, Transfer

Autor:innen und Institutionen

  • Department of Pharmacology, Monash Biomedicine Discovery Institute,Monash University, Clayton, Victoria, Australia.
  • Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Doherty Applied Microbial Genomics (DAMG), 12 Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • AgResearch Limited, Grasslands Research Center, Tennent Drive, Palmerston North, New Zealand.
  • Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.

ORCID-Profile: Maytham Hussein, Louise M Judd, Gauri G Rao, Jian Li, Kathryn E Holt, Tony Velkov

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • Bill and Melinda Gates Foundation

Zitieren

APA

Hussein, M., Sun, Z., Hawkey, J., Allobawi, R., Judd, L. M., Carbone, V., Sharma, R., Thombare, V., Baker, M., Rao, G. G., Li, J., Holt, K. E., & Velkov, T. (2024). High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis. mSystems. https://doi.org/10.1128/msystems.00972-23

Vancouver

Hussein M, Sun Z, Hawkey J, Allobawi R, Judd LM, Carbone V, et al. High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis. mSystems. 2024. doi:10.1128/msystems.00972-23

BibTeX
@article{Hussein2024,
  author = {Hussein, Maytham and Sun, Zetao and Hawkey, Jane and Allobawi, Rafah and Judd, Louise M and Carbone, Vincenzo and Sharma, Rajnikant and Thombare, Varsha and Baker, Mark and Rao, Gauri G and Li, Jian and Holt, Kathryn E and Velkov, Tony},
  title = {High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis},
  journal = {mSystems},
  year = {2024},
  doi = {10.1128/msystems.00972-23}
}
Kostenlos starten →